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Introduction: This is a case of a patient who had a history of grossly increasing abdominal distension for 6 
months. The patient had no symptoms except pressure symptoms with a regular menstrual cycle. She initially 
was investigated as a case of abdominal distension and indigestion. With increasing size, the discomfort was the 
main symptom. She attended our Gynaecology Outpatient department and was diagnosed as a case of Large 
Ovarian mass.  The first investigation performed was Pelvic ultrasound and Tumour markers and a Risk of 
malignancy index were calculated. Her Magnetic resonance imaging with contrast showed a large well 
encapsulated ovarian mass with no ascites and no metastasis. After getting all the investigations and discussion 
with the patient a  Staging Laparotomy with Total abdominal hysterectomy and bilateral salpingo-oophorectomy 
was performed, The ureters were stented before laparotomy to avoid damage to the ureters during surgery. She 
was diagnosed as Stage 1-A at the time of surgery and had an uneventful recovery. Her histopathology report 
showed a unilateral Mucinous cystadenocarcinoma with negative peritoneal wash and omentum histopathology. 
Keywords: Mucinous ovarian carcinoma (MOC ), Staging laparotomy, Computerized tomography CT, Total 
abdominal hysterectomy with bilateral salpingo-oophorectomy, Carcinoma intraepithelial neoplasia (CIN), 
Carcinoembryonic antigen (CEA).  
 




My patient Mrs. K I aged 38 yrs attended our OPD at 
Dr. Akbar Niazi Teaching Hospital (DANTH), Bara 
Kahu, Islamabad in August 2018 with a h/o 
generalized distention of the abdomen and early 
satiety since 6 months. She was P6 all spontaneous 
vaginal deliveries. She had a regular cycle of 6/30 
days with no associated dysmenorrhea. On 
examination, she was found to have a huge cystic mass 
in her abdomen arising from the pelvis reaching her 
epigastrium. The lower limit of the mass was not 
reachable. The mass was soft, cystic, fluctuant, and 
non-tender. She is a known Diabetic on oral 
hypoglycemic for 2 yrs but with poor control. She did 
not have any other significant medical or surgical 
history. She didn’t have any family history of Breast or 
Ovarian cancers and any history of Oral contraceptive 
use. 
Her routine investigations were carried out which 
included her CBC, LFTs, RFT’s were normal. Her 
HbA1c was 7.2%. Her CXR was clear with normal 
cardiac shadow and clear lungs with no pleural 
effusion.  An ultrasound abdomen and pelvis along 
with a contrast CT were performed. 
Ultrasound abdomen and Pelvis showed normal-sized 
uterus with thin endometrial lining, right ovary looked 
normal while a cystic solid mass was seen filling up 
the abdomen size 36 cm x 35 cm arising from the left 
adnexa. There were projections visualized on 
ultrasound inside the large mass Minimal ascites was 
seen.  
The patient underwent a contrast CT scan abdomen 
and pelvis as part of the staging procedure to plan the 
extent of surgery. Films of contrast CT  
  
Figure 1: CT Scan report  
A huge mass size 36 cm x 35 cm arising from the left 
adnexa with solid and cystic areas left ovary not seen 
separately. It is occupying the whole abdominal cavity 
with an intact capsule with no ascites or suspicion of 
spread. There are no enlarged lymph nodes. The 
uterus and right ovary are normal with no evidence of 
involvement of the urinary bladder or rectum. 




The patient was counseled along with family 
regarding the diagnosis and consented to a Staging 
Laparotomy and Total abdominal hysterectomy and 
bilateral salpingo-oophorectomy because of the mass 
size, her age, and complete family. The urologist and 
surgeon were also requested to review the patient as 
clinically malignancy was suspected. 
 She underwent surgery on 17 September 2018. The 
urologist did a cystoscopy and both ureters were 
stented with double J stents for easy identification of 
the ureters during surgery. Surgery was performed 
through a sub umbilical midline incision. On entering 
the peritoneal cavity no ascites were visualized so 
peritoneal wash was taken for cytology from Pouch of 
Douglas. There were no adhesions although the mass 
was huge it was freely mobile with an intact capsule 
arising from the left adnexa. The ovarian mass was 
removed and Total abdominal hysterectomy, bilateral 
salpingo-oophorectomy, and infra colic omentectomy 
were performed. No enlarged lymph nodes were 
encountered during surgery. No drains were kept 
intraperitoneally. Her uterus, fallopian tubes, and 
right ovary were grossly normal. Omentum showed 
some thickening there were no signs of any metastasis 
in the peritoneal cavity.  The abdomen was closed in 
layers and the skin was closed with interrupted 
sutures. 
She has been surgically staged as STAGE I A, 
OVARIAN CANCER. She had an uneventful 
postoperative recovery and discharged home in a 
stable condition on Day 5 with follow-up for suture 
removal and histopathology report. 
Her histopathology report showed Left ovarian 
cystadenocarcinoma of the mucinous type. normal 
uterus and right ovary with no evidence of 
malignancy. Omentum showed inflammatory changes 
only and peritoneal wash was negative for malignant 
cells. 
She is being referred for Further treatment and 
Chemotherapy to NORI. 
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Most of the Ovarian cancers are Epithelial which 
include the Serous and Mucinous tumors. The 
mucinous tumors can be benign, borderline, 
malignant, and sometimes present with pseudo 
myxoma peritonei. All these tumors show a 
progressive relationship like CIN to cervical cancer 
which is usually not present with other types of 
ovarian tumors. In molecular behavior, Epithelial 
ovarian tumors show p53 and BRCA mutations while 
mucinous ovarian tumors show KRAS mutations. 
The most common Ovarian malignancies are Epithelial 
and of the Serous type. Mucinous ovarian carcinoma 
(MOC), is less than five percent of all epithelial 
ovarian malignancies.1 All early-stage epithelial 
ovarian malignancies are treated, with Removal of the 
mass and a total abdominal hysterectomy with 
bilateral salpingo-oophorectomy. In advanced 
malignancies debulking surgery/or tumor reduction, 
and adjuvant chemotherapy with a Taxane and a 
platinum agent is required.  
Mucinous cystadenomas present as a large, 
multiloculated cystic mass with mucus-containing 
fluid.2 They are common in women in their 
reproductive years but cases in adolescent and pre-
menarchal girls and postmenopausal patients, have 
been reported.3 The average size at presentation is 18 
cm. Mucinous tumors can become extremely large like 
in our case and fill the entire abdominal cavity i.e. 
from the pelvis to the diaphragm. They can cause 
ureteral obstruction or abdominal compartment 
syndrome due to pressure.4 When dealing with 
ovarian tumors clinically if the mass is large it’s 
usually mucinous. Primary mucinous tumors are 
larger and unilateral, while metastatic lesions are 
smaller and bilateral. 
A relationship between tumor size and laterality was 
studied by Seidman et al. In their study they found 
that a unilateral tumor greater than 10 cm correctly 
predicted primary ovarian tumors in 82 % of cases. In 
patients having bilateral ovarian tumors and size less 
than 10 cm, metastatic disease was correctly predicted 
in 95 % of cases. Other studies have later confirmed 
this relationship.5 
Mucinous ovarian cancers are diagnosed at Stage I in 
83%of the cases and only 17% are Stage II or above. 
Meanwhile Serous ovarian carcinomas 4 % of patients 
are diagnosed at Stage I and 96 % are stage II or above 
at the time of diagnosis. Thereby the prognosis is 
better with primary mucinous tumors. 
Many studies have confirmed that a mucinous tumor 
limited to the ovary will not have occult lymph node 
metastasis. Therefore, it is not considered evidence-
based to perform routine pelvic and/or para-aortic 
lymphadenectomy as part of the staging procedure.6 
The most useful tumor marker for MOC is the 
Carcinoembryonic antigen (CEA). It is used 
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preoperatively and postoperatively to follow a patient 
with MOC.  
While the most useful tumors marker in Serous 
ovarian is elevated CA125.7 
The gold standard for the treatment of MOC includes 
a staging laparotomy, peritoneal wash, total 
hysterectomy, bilateral salpingo-oophorectomy, and 
infra colic omentectomy. 
As the MOC’s are usually diagnosed at an early stage 
and are unilateral, young patients can undergo 
fertility-sparing surgery with no adverse effect on their 
prognosis.  
Staging in patients who have completed their families 
includes a midline incision laparotomy, a thorough 
evaluation of the peritoneal cavity with a sampling of 
any suspicious areas, pelvic washings, total abdominal 
hysterectomy with bilateral salpingo-oophorectomy, 
and infracolic omentectomy.8 A sampling of the pelvic 
and para-aortic lymph nodes is not done routinely as 




Primary Mucinous ovarian tumors are different in 
many aspects from the other Epithelial ovarian 
tumors. They differ in their etiology, early 
presentation, tumor markers, clinical progression of 
the disease, and survival rates. A small number of 
cases of MOC need to be studied further to achieve 
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